Primary Objectives~-To evaluate the feasibility of lenalidomide maintenance therapy in patients with relapsed Hodgkin lymphoma after autologous stem cell transplant, as measured by dropout rate.~Secondary Objectives~To assess overall survival, event free survival, and progression free survival.~To establish the adverse event profile of long-term maintenance therapy with lenalidomide in this patient population.~To assess the conversion of partial response/stable disease post-ASCT to complete response.~To evaluate changes in immune cell number and function and plasma proteins before, during, and after lenalidomide therapy (correlative studies).
The purpose of this study to evaluate the feasibility of lenalidomide maintenance therapy in patients with relapsed Hodgkin lymphoma after autologous transplant